Effect of 25-hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients

Prostate

Volumn 71, Issue 4, 2011, Pages 368-372

  Chadha, Manpreet K ^a   Fakih, Marwan ^a   Muindi, Josephia ^a   Tian, Lili ^b   Mashtare, Terry ^b   Johnson, Candace S ^a   Trump, Donald ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

influenza; titer; vaccine; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; AGGLUTININ; INFLUENZA VACCINE;

ADULT; AGE; AGED; ARTICLE; CANCER CENTER; CANCER PATIENT; CHEMOTHERAPY; HEMAGGLUTINATION INHIBITION; HUMAN; INFLUENZA VACCINATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; RADIOIMMUNOASSAY;

AGED; HUMANS; INFLUENZA VACCINES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; VITAMIN D;

EID: 79251477886     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21250     Document Type: Article

References (23)

1. Cannell JJ, Vieth R, Umhau JC, Holick MF, Grant WB, Madronich S, Garland CF, Giovannucci E,. Epidemic influenza and vitamin D. Epidemiol Infect 2006; 134: 1129-1140.
2. Hope-Simpson RE, Golubev DB,. A new concept of the epidemic process of influenza A virus. Epidemiol Infect 1987; 99: 5-54.
3. Cannell JJ, Zasloff M, Garland CF, Scragg R, Giovannucci E,. On the epidemiology of influenza. Virol J 2008; 5: 29.
4. Aloia JF, Li-Ng M,. Correspondence. Epidemiol Infect 2007; 135: 1095-1096.
5. Robinson RQ, Dowdle WR,. Influenza viruses. In:, Lennette EH, Schmidt NJ, editors. Diagnostic procedures for viral and rickettsial infections, 4th edition. New York: American Public Health Association, Inc.; 1969. pp. 414-433.
6. Hobson D, Curry RL, Beare AS,. Hemagglutination-inhibiting antibody titres as a measure of protection against influenza in man. In:, Perkins FT, Regamy RH, editors. International Symposium on Influenza Vaccines for Men and Horses, London, 1972. Symposium Series of Immunological Standardization, No. 2. New York: Karger; 1973. pp. 164-168.
7. Stiver HG, Graves P, Eickhoff TC, Meiklejohn G,. Efficacy of "Hong Kong" vaccine in preventing "England" variant influenza in 1972. N Engl J Med 1973; 289: 1267-1271.
8. Hollis BW,. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency; implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005; 135 (2): 317-322.
9. Wang TT, Nestel FP, Bourdeau V, et al. Cutting edge: 1,25- dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 2004; 173: 2909-2912.
10. Gombart AF, Borregaard N, Koeffler HP,. Human cathelicidin antimicrobial peptide gene is a direct target of the vitamin D receptor and is strongly upregulated in myeloid cells by 1,25 dihydroxy vitamin D3. FASEB J 2005; 19: 1067-1077.
11. Zasloff M,. Fighting infections with vitamin D. Nat Med 2006; 12: 388-390.
12. Laube DM, Yim S, Ryan LK, Kisich KO, Diamond G,. Antimicrobial peptides in the airway. Curr Top Microbiol Immunol 2006; 306: 153-182.
13. Trump DL, Chadha MK, Sunga AY, et al. Vitamin D deficiency and insufficiency among patients with prostate cancer. BJU Int 2009; 104 (7): 909-914.
14. Fakih MG, Trump DL, Johnson CS, et al. Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer. Int J Colorectal Dis 2009; 24 (2): 219-224.
15. Bartley J,. Vitamin D, innate immunity and upper respiratory tract infection. J Laryngol Otol 2010; 124 (5): 465-469.
16. Hiemstra PS,. The role of epithelial beta-defensins and cathelicidins in host defense of the lung. Exp Lung Res 2007; 33 (10): 537-542.
17. Kriesel JD, Spruance J,. Calcitriol 1,25-dihydroxy-vitamin D3 coadministered with influenza vaccine does not enhance humoral immunity in human volunteers. Vaccine 1999; 17: 1883-1888.
18. Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H,. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 2010; 91 (5): 1255-1260.
19. Shildt RA, Luedke DW, Kasai G, El-Beheri S, Laham MN,. Antibody response to influenza immunization in adult patients with malignant disease. Cancer 1979; 44 (5): 1629-1635.
20. Brydak LB, Machala M,. Humoral immune response to influenza vaccination in patients from high risk groups. Drugs 2000; 60 (1): 35-53.
21. Anderson H, Petrie K, Berrisford C, Charlett A, Thatcher N, Zambon M,. Seroconversion after influenza vaccination in patients with lung cancer. Br J Cancer 1999; 80 (1-2): 219-220.
22. Gross PA, Gould AL, Brown AE,. Effect of cancer chemotherapy on the immune response to influenza virus vaccine: Review of published studies. Rev Infect Dis 1985; 7 (5): 613-618.
23. Ramanathan RK, Potter DM, Belani CP, et al. Randomized trial of influenza vaccine with granulocyte-macrophage colony-stimulating factor or placebo in cancer patients. J Clin Oncol 2002; 20 (21): 4313-4318.